¾ÆÀ̵ð
Á¦ ¸ñ
ºñ¹Ð¹øÈ£
³» ¿ë
I do some voluntary work
pyridium discontinued
AbbVie announced positive interim Phase-III results Thursday for its endometriosis drug elagolix, but one analyst says its commercial impact is likely linked to its effect on patients' bone mineral density.